Form 4: Precision BioSciences General Counsel Sells Shares to Cover Tax Obligations After RSU Vesting

Precision BioSciences' General Counsel, Dario Scimeca, sold 8,928 shares of common stock to cover tax obligations following the vesting of restricted stock units.

Summary

• Dario Scimeca, General Counsel and Secretary of Precision BioSciences, Inc., executed transactions involving the company's stock.
• On January 20, 2025, Scimeca's restricted stock units (RSUs) partially vested, resulting in the acquisition of 25,312 shares.
• Following the vesting, Scimeca sold 8,928 shares on January 22, 2025, at a price of $4.79 per share.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on July 14, 2023.
• The shares were sold solely to cover tax withholding obligations related to the vesting of the RSUs.
• Scimeca did not sell shares for any other reason than to cover required taxes and fees.
• The vesting of RSUs was related to grants made on January 20, 2023, April 18, 2024, and August 22, 2024, which vest in three annual installments.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction for tax purposes, which is generally neutral. The use of a 10b5-1 plan adds a layer of transparency and reduces the risk of negative market perception.

Positives

• The transactions were part of a pre-planned trading strategy under Rule 10b5-1, indicating no unexpected insider selling.
• The sale was solely to cover tax obligations, suggesting no negative sentiment from the executive regarding the company's future.

Risks

• While the sale was for tax purposes, large volumes of insider sales can sometimes be perceived negatively by the market.

Management Comments

• The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.

Industry Context

Insider transactions are a normal part of corporate activity, especially when executives receive equity compensation. The use of a Rule 10b5-1 plan is a common practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is a standard practice among publicly traded companies to manage insider sales.
• The vesting schedules of RSUs are typical, with three-year vesting periods being common.
• The sale of shares to cover tax obligations is a routine occurrence for executives receiving equity compensation.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although the pre-planned nature of the sale mitigates this risk.
• The sale has no direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

insider trading, Form 4, restricted stock units, RSU, Rule 10b5-1, Precision BioSciences, Dario Scimeca, stock sale, tax obligations, vesting